AUTHOR REPLY - 04/11/20
Doi : 10.1016/j.urology.2020.05.103
Shannon E. Ciprut 1, 2, 3, Matthew D. Kelly 1, 2, 3, ⁎, Dawn Walter 1, 2, 3, Danil V. Makarov 1, 2, 3, 4, 5
1 VA New York Harbor Healthcare System, New York, NY
2 Department of Urology, New York University, New York, NY
3 Department of Population Health, New York University, New York, NY
4 Perlmutter Cancer Center, New York University, New York, NY
5 Robert F. Wagner Graduate School of Public Service, New York University, New York, NY
⁎Address correspondence to: Matthew Kelly, 227 E 30th St, Office 617L, New York, NY 10016.227 E 30th St Office 617LNew YorkNY10016
Le texte complet de cet article est disponible en PDF.
| Funding for this study was provided by the United States Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service (VA IIR 15-356). This study is supported by The Prostate Cancer Foundation (PCF), The John and Daria Barry Precision Oncology Center of Excellence of the VANYHHS, and The Edward Blank and Sharon Cosloy–Blank Family Foundation. Dr. Makarov is a Prostate Cancer Foundation Young Investigator awardee. The views expressed in this article are those of the author(s) and do not necessarily represent the views of the Department of Veteran Affairs. |
© 2020
Publié par Elsevier Masson SAS.
Vol 145
P. 119 - novembre 2020 Retour au numéro
Article précédent
- EDITORIAL COMMENT
- Marc B. Garnick, David J. Einstein
- Stakeholder Perspective on Opioid Stewardship After Prostatectomy: Evaluating Barriers and Facilitators From the Pennsylvania Urology Regional Collaborative
- Daniel J. Lee, Ruchika Talwar, James Ding, Thenappan Chandrasekar, Kaynaat Syed, Claudette Fonshell, John Danella, Serge Ginzburg, Thomas Lanchoney, Jeffrey Tomaszewski, Edouard Trabulsi, Adam Reese, Marc Smaldone, Robert Uzzo, Jay D. Raman, Thomas J. Guzzo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?